Press Releases

Accuray to Participate in the Jefferies 2015 Healthcare Conference SUNNYVALE, Calif., May 26, 2015-- Accuray Incorporated (Nasdaq: ARAY), announced today that its management team is scheduled to present at the Jefferies 2015 Healthcare Conference in New York on Wednesday, June 3, 2015 at 2:30pm ET. Read More »
Accuray to Participate in the Bank of America Merrill Lynch 2015 Healthcare Conference SUNNYVALE, Calif., May 5, 2015-- Accuray Incorporated (Nasdaq: ARAY), announced today that its management is scheduled to present at the Bank of America Merrill Lynch 2015 Healthcare Conference in Las Vegas on Tuesday, May 12, 2015 at 2:20pm PT. Read More »
Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software SUNNYVALE, Calif., April 30, 2015 – Accuray Incorporated (Nasdaq: ARAY) announced today that it has signed an agreement with MIM Software Inc. to further develop adaptive therapy software for the TomoTherapy® and CyberKnife® product portfolios. The new software solution will leverage both Accuray and MIM technology. This is Accuray's second collaboration with MIM; the previous partnership led to the development of the first iPad-based treatment plan review capability, PlanTouch™. Read More »
Accuray Reports Financial Results for Third Quarter of Fiscal Year 2015 SUNNYVALE, Calif., April 30, 2015 – Accuray Incorporated (Nasdaq: ARAY) announced today financial results for the third fiscal quarter and nine months ended March 31, 2015. Read More »
Accuray to Showcase New CyberKnife® and TomoTherapy® Technologies at ESTRO 2015 Sunnyvale, Calif., April 23, 2015 – Accuray Incorporated (Nasdaq: ARAY) announced today that the company will highlight new CyberKnife® and TomoTherapy® technologies at the European Society for Therapeutic Radiology and Oncology (ESTRO) meeting, booth #2100, in Barcelona, Spain, April 24 – 27, 2015. The CyberKnife and TomoTherapy Systems are used to treat cancerous and benign tumors throughout the body. Each system precisely targets the tumor, delivering the prescribed radiation dose, while minimizing exposure to nearby healthy organs and tissues. Read More »
Accuray Initiates International Commercial Launch of the InCise™ Multileaf Collimator for the CyberKnife® M6™ System SUNNYVALE, Calif., April 21, 2015 -- Accuray Incorporated (Nasdaq: ARAY) announced today that the InCise™ Multileaf Collimator (MLC) for the CyberKnife® M6™ System will now be available outside the United States in markets where it is approved for sale, in addition to the U.S. market where the InCise MLC was commercially launched in February 2015. Read More »
Accuray Establishes First TomoTherapy® and CyberKnife® System Education Centers in China SUNNYVALE, Calif., April 13, 2015 – Accuray Incorporated (Nasdaq: ARAY) announced today that they have collaborated with leading cancer hospitals to establish professional radiotherapy education centers in China. The goal of these centers is to use clinical training and continuing education to provide practitioners with education on the use of radiation to treat cancerous tumors. With the rapid development of cancer treatment techniques, radiotherapeutic equipment upgrades and adoption of new radiotherapy technologies, there is an opportunity to provide practitioners with additional information on the role of radiation therapy in cancer management. Read More »
Accuray To Report Results For Third Quarter Fiscal 2015 On April 30, 2015 SUNNYVALE, Calif., April 9, 2015 -- Accuray Incorporated (NASDAQ: ARAY) will report results for its third quarter ended March 31, 2015 on April 30, 2015 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT/4:30 p.m. ET on the same day. Read More »

Pages